Pemazyre^®▼ (pemigatinib)

This page is intended as reference information for the general public in The United Kingdom & Ireland.

For more information on this product, please visit the electronic Medicines Compendium (eMC).

This medicine is subject to additional monitoring. This will allow quick identification of new safety information.

If you get any side effects when taking this or any other medicine, talk to your doctor or other relevant health professional, e.g., pharmacist, nurse. This includes any possible side effects not listed in the packaging leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search the Google Play or Apple App Store for MHRA Yellow Card. By reporting side effects, you can help provide more information on the safety of this medicine.

Incyte is unable to provide advice on personal medical matters. Please consult your doctor or other relevant health professional for specific, health-related advice and support.